SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-017002
Filing Date
2021-02-10
Accepted
2021-02-10 06:35:30
Documents
1
Group Members
ARMEN B. SHANAFELT, PH.D.S. EDWARD TORRESSTEVEN E. HALL, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm215744d2_sc13ga.htm SC 13G/A 123863
  Complete submission text file 0001104659-21-017002.txt   125544
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 21609235
SIC: 2834 Pharmaceutical Preparations

Mailing Address 115 WEST WASHINGTON STREET SUITE 1680 - SOUTH INDIANAPOLIS IN 46204
Business Address 115 WEST WASHINGTON STREET SUITE 1680 - SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
LV Management Group, LLC (Filed by) CIK: 0001681884 (see all company filings)

IRS No.: 460635483 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A